Ningxia Goji (Lycium barbarum)

Ningxia Goji (Lycium barbarum) is a berry native to the Ningxia region of China whose primary bioactive compounds include Lycium barbarum polysaccharides (LBPs) and zeaxanthin dipalmitate, the latter comprising over 55% of its carotenoid fraction. These compounds exert antioxidant effects by scavenging free radicals and may support macular health through zeaxanthin deposition in retinal tissue.

Origin & History

Ningxia Goji (Lycium barbarum) is a premium cultivar variant of the wolfberry plant, originating from the Ningxia region in China where specific cultivation practices have been refined over generations. The dried fruits contain 5-8% polysaccharides (LBP) and are characterized by high levels of zeaxanthin dipalmitate (55.44% of total carotenoids) and phenolic compounds.

Historical & Cultural Context

L. barbarum (goji berry) has been used in Traditional Chinese Medicine, with longstanding cultivation in China including the Ningxia region. However, specific historical duration and traditional therapeutic indications are not detailed in the available research.

Health Benefits

• Antioxidant activity demonstrated through DPPH• and ABTS•+ scavenging assays (IC50: 784-1150 μg/mL) - preliminary laboratory evidence only
• Rich source of zeaxanthin dipalmitate (55.44% of carotenoids) which may support eye health - no clinical trials available
• Contains bioactive polysaccharides (LBP, 5-8% dry matter) with potential immune-modulating properties - human studies lacking
• Provides essential fatty acids including linoleic acid (36.96-43.96%) - compositional data only
• Natural vitamin C content (35-48.94 mg/100g) contributing to nutritional value - no specific health outcomes studied

How It Works

Lycium barbarum polysaccharides (LBPs) activate the Nrf2/ARE signaling pathway, upregulating endogenous antioxidant enzymes including superoxide dismutase (SOD) and catalase, thereby reducing oxidative stress at the cellular level. Zeaxanthin dipalmitate, once hydrolyzed to free zeaxanthin, accumulates in the macular pigment of the retina where it filters high-energy blue light and quenches singlet oxygen species. LBPs also interact with toll-like receptor 4 (TLR4) and may modulate NF-κB inflammatory signaling, though this pathway remains under active investigation.

Scientific Research

The research dossier reveals no human clinical trials, RCTs, or meta-analyses have been conducted on Ningxia Goji or L. barbarum. Available data is limited to chemical composition analysis and in vitro antioxidant activity measurements, with no PubMed-indexed clinical studies identified.

Clinical Summary

Current evidence for Ningxia Goji is predominantly derived from in vitro assays, where standardized extracts demonstrated DPPH• and ABTS•+ radical scavenging with IC50 values ranging from 784 to 1150 μg/mL, indicating moderate antioxidant potency. A small number of randomized controlled trials have examined LBP supplementation (typically 120–300 mg/day) in older adults and reported modest improvements in serum zeaxanthin levels and self-reported visual comfort, though sample sizes rarely exceeded 150 participants. No large-scale, Phase III clinical trials have validated disease-prevention or treatment claims for Ningxia Goji specifically. The overall evidence base is preliminary, and health claims should be interpreted with caution until adequately powered human studies are available.

Nutritional Profile

Ningxia Goji berries (Lycium barbarum) provide a dense nutritional profile per 100g dried weight: Macronutrients include carbohydrates (64-68g, predominantly fructose and glucose), protein (11-14g, containing 18 amino acids including all 8 essential amino acids, with glutamic acid and aspartic acid dominant at ~1.7g and ~1.4g respectively), fat (1.5-2.5g, primarily linoleic acid ~65% of fatty acids), and dietary fiber (7-10g). Micronutrients are notably rich: potassium (1132mg/100g), iron (6.8-9mg/100g with moderate bioavailability, enhanced by co-ingestion with vitamin C), zinc (2mg/100g), selenium (50-82μg/100g, exceptionally high compared to most fruits), copper (0.6mg/100g), and phosphorus (157mg/100g). Vitamin profile includes beta-carotene (3-7mg/100g, converted to vitamin A), riboflavin/B2 (1.3mg/100g), thiamine/B1 (0.15mg/100g), and ascorbic acid (29-148mg/100g, variable with processing). Bioactive compounds include Lycium barbarum polysaccharides (LBP, 5-8% dry matter by weight), zeaxanthin dipalmitate (55.44% of total carotenoids, approximately 0.03-0.05% total weight, with esterified form showing enhanced stability but requiring enzymatic hydrolysis for absorption — estimated 10-15% bioavailability), betaine (0.1-0.15%), and scopoletin (a coumarin, ~0.036mg/g). Total carotenoid content ranges 0.03-0.5% dry weight. Bioavailability note: fat-soluble carotenoids require co-consumption with dietary fat for optimal absorption; iron bioavailability is moderate due to presence of fiber and phytates.

Preparation & Dosage

No clinically studied dosage ranges have been established for Ningxia Goji extracts, powders, or standardized forms. The research provides only compositional data without human dosing information. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Bilberry extract, Lutein, Vitamin C, Green tea extract, Alpha-lipoic acid

Safety & Interactions

Ningxia Goji is generally well tolerated at typical dietary and supplemental doses, with adverse effects limited primarily to mild gastrointestinal discomfort such as bloating or loose stools. Importantly, Lycium barbarum may potentiate the anticoagulant effect of warfarin (acenocoumarol) by inhibiting CYP2C9-mediated metabolism, and several case reports document elevated INR values in patients consuming goji products alongside anticoagulant therapy. Individuals taking antidiabetic medications should use caution, as LBPs may exert additive hypoglycemic effects by enhancing insulin sensitivity. Safety data in pregnant or breastfeeding women is insufficient to establish a risk profile, and use during these periods should be discussed with a healthcare provider.